Microba Life Sciences Share Price and Company Fundamentals



Price
$0.035
Change
0.000 (0.000%)
52 week range
0.033 - 0.105

Last traded: Today at 11:00 PM

Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates through, Testing Services and Supplements, and Research and Development segments. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; microba microbiome explorer; research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel autoimmune diseases, oncology, and allergy. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.

Key Metrics

PE ratio

-

PB ratio

1.00

Dividend yield

0.00%

Beta

2.14

Market cap

$26.00M

Enterprise value

$20.67M

Company profile

Industry / Sector Diagnostics & Research / Healthcare
Website https://microba.com
Mailing address 324 Queen Street Level 10 Brisbane QLD 4000 Australia
Phone / Fax /

Dividends

More: Microba Life Sciences Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$-

Payout ratio

-

5Y Avg. yield

-%

Microba Life Sciences paid $- dividend and the ex-dividend date was -.The dividend payout ratio is -. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.

Company Executives

As of Nov 2026, following are the company executives and directors listed on Microba Life Sciences.

Name Title Age Total Pay
Mr. James Heath CFO & Company Secretary
Dr. Luke Reid Chief Executive Officer (Leave of Absence)
Mr. Geoffrey C. Cockerill Interim Chief Executive Officer
Prof. Philip Hugenholtz Co-Founder & Chair of Scientific Advisory Board
Dr. David Wood Chief Technology Officer
Prof. Lutz Krause Chief Scientific Officer

Profitability and management effectiveness

Profit margin

-140.40%

Operating margin

-137.58%

Return on assets

-29.09%

Return on equity

-72.87%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Microba Life Sciences is 26.00M and its enterprise value is 20.67M. The enterprise value to revenue ratio of MAP is 1.40. The enterprise value to EBITDA ratio of MAP is -1.11.

The MAP's stocks Beta value is 2.14 making it 114% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Microba Life Sciences (MAP)

Microba Life Sciences (ASX:MAP) Frequently Asked Questions

1. What is Microba Life Sciences's Stock Symbol?

Microba Life Sciences trades on ASX under the ticker symbol "MAP".

2. What is Microba Life Sciences's stock price today?

One share of MAP stock can currently be purchased for approximately $0.035.

3. How can I contact Microba Life Sciences?

Microba Life Sciences's mailing address is 324 Queen Street Level 10 Brisbane QLD 4000 Australia. The company can be reached via phone at .

4. What is Microba Life Sciences's official website?

The official website of Microba Life Sciences is https://microba.com.